...
首页> 外文期刊>PLoS Pathogens >Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1
【24h】

Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1

机译:重新审视受人巨细胞病毒立即早期蛋白质1的临时细胞白血病蛋白1

获取原文
           

摘要

Promyelocytic leukemia (PML) bodies are nuclear organelles implicated in intrinsic and innate antiviral defense. The eponymous PML proteins, central to the self-organization of PML bodies, and other restriction factors found in these organelles are common targets of viral antagonism. The 72-kDa immediate-early protein 1 (IE1) is the principal antagonist of PML bodies encoded by the human cytomegalovirus (hCMV). IE1 is believed to disrupt PML bodies by inhibiting PML SUMOylation, while PML was proposed to act as an E3 ligase for IE1 SUMOylation. PML targeting by IE1 is considered to be crucial for hCMV replication at low multiplicities of infection, in part via counteracting antiviral gene induction linked to the cellular interferon (IFN) response. However, current concepts of IE1-PML interaction are largely derived from mutant IE1 proteins known or predicted to be metabolically unstable and globally misfolded. We performed systematic clustered charge-to-alanine scanning mutagenesis and identified a stable IE1 mutant protein (IE1cc172-176) with wild-type characteristics except for neither interacting with PML proteins nor inhibiting PML SUMOylation. Consequently, IE1cc172-176 does not associate with PML bodies and is selectively impaired for disrupting these organelles. Surprisingly, functional analysis of IE1cc172-176 revealed that the protein is hypermodified by mixed SUMO chains and that IE1 SUMOylation depends on nucleosome rather than PML binding. Furthermore, a mutant hCMV expressing IE1cc172-176 was only slightly attenuated compared to an IE1-null virus even at low multiplicities of infection. Finally, hCMV-induced expression of cytokine and IFN-stimulated genes turned out to be reduced rather than increased in the presence of IE1cc172-176 relative to wild-type IE1. Our findings challenge present views on the relationship of IE1 with PML and the role of PML in hCMV replication. This study also provides initial evidence for the idea that disruption of PML bodies upon viral infection is linked to activation rather than inhibition of innate immunity.
机译:早幼粒细胞白血病(PML)尸体是核心体,涉及内在和先天抗病毒防御。在这些细胞器中发现的自我组织的同名PML蛋白质,对PML体的自我组织的核心以及其他限制因子是病毒拮抗作用的常见目标。 72-KDA立即早期蛋白1(IE1)是由人巨细胞病毒(HCMV)编码的PML体的主要拮抗剂。据信IE1通过抑制PML SuMOlation来破坏PML体,而PML被提出为IE1 SuMoylate的E3连接酶。通过IE1靶向的PML靶向对于低多重感染在低多个感染中的HCMV复制至关重要,部分通过与细胞干扰素(IFN)反应连接的抵抗抗病毒基因诱导。然而,IE1-PML相互作用的当前概念主要来自已知或预测的突变体IE1蛋白质是代谢不稳定并且全球错误的。我们进行了系统的聚类电荷 - 丙氨酸扫描诱变,并鉴定了稳定的IE1突变蛋白(IE1cc172-176),除了与PML蛋白没有相互作用,除非与PML蛋白相互作用,也没有抑制PML Sumoylation。因此,IE1CC172-176不与PML体相关联,并选择性地损害以破坏这些细胞器。令人惊讶的是,IE1cc172-176的功能分析显示,通过混合的Sumo链蛋白质对蛋白质高渗,IE1 Sumoylation取决于核小体而不是PML结合。此外,与IE1-NULL病毒甚至在低多重感染时,表达IE1c172-176的突变HCMV仅略微衰减。最后,HCMV诱导的细胞因子和IFN刺激基因的表达,而不是在IE1CC172-176相对于野生型IE1存在下增加而不是增加。我们的调查结果挑战了对IE1与PML的关系的看法以及PML在HCMV复制中的作用。本研究还提供了初步证据,即观察病毒感染后PML体的破坏与激活而非抑制先天免疫。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号